Antibodies are the immune system's precision tools for recognizing and neutralizing viruses, bacteria and other foreign ...

Alfa Cytology offers specialized radiolabeling and antibody-radionuclide conjugate development to advance radiopharmaceutical ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. In April 2021, the FDA approved the 100th monoclonal ...

For therapies based on monoclonal antibodies (mAbs), bioprocessors continually search for ways to improve the development process. Machine learning (ML) offers one useful tool. As Mariano Nicolas Cruz ...

Researchers at Colorado State University have determined how to use artificial intelligence to modify antibodies so they act ...

AI has been hailed as a way to speed up historically sluggish drug development, but an entirely AI-designed drug has yet to be approved by the FDA. The furthest along is likely Insilico Medicine’s ...

Monoclonal antibodies (mAbs) aid the body against autoimmune diseases and cancer, among other things. Patients have to pick ...

ABS-101 clinical results and ABS-201 catalysts in 2026, plus competitor context. Click here to read my analysis.

A lack of targeting specificity has been a long-running problem for cytotoxic anticancer agents, with excess side effects limiting their effectiveness. Scientists have turned to antibodies, and their ...

VICTORIA, British Columbia--(BUSINESS WIRE)-- ImmunoPrecise Antibodies Ltd. (the “Company” or “IPA”) (NASDAQ: IPA), a leader in AI-driven medical innovation, is proud to announce a significant ...

iBio (IBIO) in collaboration with AstralBio announced the development of an antibody that inhibits the function of Activin E, a promising therapeutic target for cardiometabolic disorders and obesity ...